EUVIMEDEUVIMED entdecken
Crossref

Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study

Ching-Yuan Cheng, Wen-Chen Chuang, Ching-Pin Lin, Che-Hsing Li, Hui-Yi Chang, Wen-Jun Wu, Ming-Fang Wu, Jiunn-Liang Ko

Cancer Chemotherapy and Pharmacology · 2025

DOI: 10.1007/s00280-024-04734-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Ching-Yuan Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, 500209, Taiwan. Hauptthemen laut MEDLINE: Pemetrexed, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Endoglin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Chung Shan Medical University Hospital, Taiwan National Science and Technology Council, Changhua Christian Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PemetrexedCarcinoma, Non-Small-Cell LungLung NeoplasmsEndoglinBiomarkers, TumorCell MovementHumansCell Line, TumorDrug Resistance, NeoplasmAntineoplastic AgentsA549 CellsCell ProliferationCell Cycle

Stichwörter der Autor:innen

BiomarkerCell cycleEndoglinMetastasisNon-small cell lung cancerPemetrexed

Substanzen

PemetrexedEndoglinBiomarkers, TumorENG protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Thoracic Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, 500209, Taiwan.
  • Division of Thoracic Surgery, Department of Surgery, Yunlin Christian Hospital, Yunlin, 648106, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, 40227, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan.
  • Institute of Medicine, Chung-Shan Medical University, Taichung, 40201, Taiwan.
  • Division of Gastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, 40201, Taiwan.

Förderung

  • Chung Shan Medical University Hospital
  • Taiwan National Science and Technology Council
  • Changhua Christian Hospital

Zitieren

APA

Cheng, C. Y., Chuang, W. C., Lin, C. P., Li, C. H., Chang, H. Y., Wu, W. J., Wu, M. F., & Ko, J. L. (2025). Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04734-9

Vancouver

Cheng CY, Chuang WC, Lin CP, Li CH, Chang HY, Wu WJ, et al. Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-024-04734-9

BibTeX
@article{Cheng2025,
  author = {Cheng, Ching-Yuan and Chuang, Wen-Chen and Lin, Ching-Pin and Li, Che-Hsing and Chang, Hui-Yi and Wu, Wen-Jun and Wu, Ming-Fang and Ko, Jiunn-Liang},
  title = {Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  doi = {10.1007/s00280-024-04734-9}
}
Kostenlos starten →